Breast Biopsy Devices Market in Europe to Reach $118.4 Million by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive European report on Breast Biopsy Devices markets. Greater disease incidence, development of newer diagnostic agents, widespread awareness among practitioners and patients and continued breakthroughs in research and clinical applications areas, will propel sales of breast biopsy devices in European market to reach $118.4 million by 2015.

Breast Biopsy Devices: A European Market Report

The market for breast care will continue to evolve globally, led by the rapidly aging population, enhanced disease screening and detection techniques, ongoing emphasis on cost-effective and minimally invasive therapies, as well as technological advancements in diagnostics and therapeutics. Given the epidemic rise in breast cancer incidences, the emphasis is presently on researching, and developing efficient detection and diagnostic regimes that help to stop or reverse disease progression, and enhance overall healthcare. In this present backdrop, opportunities will galore for manufacturers of breast biopsy devices that are continually engaged in product development, research and improvement efforts, and validation of new applications to existing products to distinguish their products from that of competitors and staying in business. Growth in biopsy Devices will be sustained by advent of broad product portfolio across the continuum of breast care, and rising awareness.

Substantial rise in cancer cases and increased public awareness about the disease are resulting in higher screening and diagnosis rates and in turn are contributing to the steady growth of European market for biopsy devices. The market for breast biopsy devices in Europe is expected to cross $118.4 million by 2015, as stated by the new market research report on Breast Biopsy Devices.

Although regional markets offer scope for expansion, price sensitivity and unclear reimbursement policies act as a stumbling block for the European Breast Biopsy Devices market. Also, the current global economic weakness has had a substantial impact on the healthcare industry. Cost-conscious consumers may make fewer elective visits to their physicians, which means lesser demand for biopsy products and procedures. Worldwide hospitals and healthcare providers are also fraught with reimbursement pressures and lowered direct government spending due to constricted budgets. The Breast healthcare segment has been impacted by the hospital-spending crisis causing the bulk of the sales decline. In US, the volume of mammograms performed has been on a decline since 2007, which as a consequence had decreased the number of breast biopsy procedures conducted nationwide. The economic downturn may also create downward pricing pressure, increase the sales cycle of certain products, and slowdown the adoption of new technology. Such an environment adversely affected the players in the biopsy devices marketplace in the last couple of years. In developed markets, such as Europe and North America, the ability to access capital is expected to remain restricted for foreseeable future.

Key players dominating the Breast Biopsy Devices marketplace include C. R. Bard Inc., Cardinal Health Inc., Ethicon Endo-Surgery Inc, GE Healthcare, Hologic Inc, iCAD Inc, Intact Medical Corporation, Koninklijke Philips Electronics N.V., Rubicor Medical Inc., Sanarus Technologies, LLC, SenoRx Inc, and Siemens AG, among others.

The report titled "Breast Biopsy Devices: A European Market Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of industry overview, key regional markets, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The report analyzes market data and provides analytics in value sales for European breast biopsy devices market.

For more details about this comprehensive market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website